Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula
- PMID: 2403699
Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula
Abstract
Chronic, nonhealing, cutaneous ulcers are a serious clinical problem. The results of previous studies using platelet-derived wound healing formula (PDWHF), derived from autologous platelets, provided evidence that PDWHF actively stimulates repair of the wound. To test whether or not PDWHF accelerates repair, a prospectively randomized, blinded trial was conducted using a placebo control. A total of 32 patients with chronic, nonhealing, cutaneous wounds of the lower extremity were randomized and treated for eight weeks with PDWHF or placebo. Epithelialization of the wound was the end point of study. In the group who received treatment, 81 per cent of patients had epithelialization in eight weeks compared with 15 per cent in the control group (p less than 0.0001). After crossover to treatment with PDWHF, all of the patients in the control group had epithelialization in an average of 7.1 weeks. Regression analysis of the rates of epithelialization also showed significant differences during the initial eight week trial and showed no difference after crossover of the control group to therapy with PDWHF. Results from this study demonstrate a highly statistically significant effect of topically applied platelet-derived growth factors on the repair of chronic, nonhealing, cutaneous ulcers.
Similar articles
-
A prospective randomized trial of autologous platelet-derived wound healing factors for treatment of chronic nonhealing wounds: a preliminary report.J Vasc Surg. 1991 Oct;14(4):526-32; discussion 532-6. J Vasc Surg. 1991. PMID: 1920650 Clinical Trial.
-
Use of homologous platelet factors in achieving total healing of recalcitrant skin ulcers.Surgery. 1990 Sep;108(3):508-12. Surgery. 1990. PMID: 2396195
-
[Clinical study of various growth factors on the improvement of impaired healing ulcers in patients with diabetic disease].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 1999 Sep;13(5):273-7. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 1999. PMID: 12080817 Chinese.
-
The use of becaplermin (rhPDGF-BB) gel for chronic nonhealing ulcers. A retrospective analysis.Clin Podiatr Med Surg. 2001 Jan;18(1):189-209, viii. Clin Podiatr Med Surg. 2001. PMID: 11344978 Review.
-
Successful methods of treating leg ulcers. The tried and true, plus the novel and new.Postgrad Med. 1999 May 1;105(5):159-61, 165-6, 173-4 passim. doi: 10.3810/pgm.1999.05.1.744. Postgrad Med. 1999. PMID: 10335328 Review.
Cited by
-
Platelet-Rich Plasma with Endothelial Progenitor Cells Accelerates Diabetic Wound Healing in Rats by Upregulating the Notch1 Signaling Pathway.J Diabetes Res. 2019 Aug 28;2019:5920676. doi: 10.1155/2019/5920676. eCollection 2019. J Diabetes Res. 2019. PMID: 31559315 Free PMC article.
-
Systematic review of the efficacy of fat grafting and platelet-rich plasma for wound healing.Int Wound J. 2018 Aug;15(4):519-526. doi: 10.1111/iwj.12892. Epub 2018 May 9. Int Wound J. 2018. PMID: 29745047 Free PMC article.
-
The LeucoPatch® system in the management of hard-to-heal diabetic foot ulcers: study protocol for a randomised controlled trial.Trials. 2017 Oct 10;18(1):469. doi: 10.1186/s13063-017-2216-9. Trials. 2017. PMID: 29017535 Free PMC article. Clinical Trial.
-
Autologous platelet-rich plasma for treating chronic wounds.Cochrane Database Syst Rev. 2016 May 25;2016(5):CD006899. doi: 10.1002/14651858.CD006899.pub3. Cochrane Database Syst Rev. 2016. PMID: 27223580 Free PMC article. Review.
-
Case report: The use of PRP in the treatment of diabetic foot: case series and a review of the literature.Front Endocrinol (Lausanne). 2023 Dec 18;14:1286907. doi: 10.3389/fendo.2023.1286907. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38170077 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical